| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8629603 | Diabetes Research and Clinical Practice | 2018 | 26 Pages |
Abstract
Serum total adiponectin and gender-specific ADIPOQ variants predict CHD and IS, but not HF, independently of other risk factors in community-based patients with T2D. In contrast to some previous studies, there was no relationship between a high serum total adiponectin and CVD.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Kirsten E. Peters, Wendy A. Davis, John Beilby, Joe Hung, David G. Bruce, Timothy M.E. Davis,